226 related articles for article (PubMed ID: 17934923)
1. CYP2A6 gene polymorphism and personality traits for NEO-FFI on the smoking behavior of youths.
Waga C; Iwahashi K
Drug Chem Toxicol; 2007; 30(4):343-9. PubMed ID: 17934923
[TBL] [Abstract][Full Text] [Related]
2. [The relationship between smoking behavior in young people and CYP2A6 gene polymorphisms, between them and personality traits assessed by NEO-FFI].
Waga C; Iwahashi K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Aug; 41(4):380-6. PubMed ID: 17037346
[TBL] [Abstract][Full Text] [Related]
3. Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.
Nakajima M
Curr Opin Mol Ther; 2007 Dec; 9(6):538-44. PubMed ID: 18041664
[TBL] [Abstract][Full Text] [Related]
4. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
Malaiyandi V; Sellers EM; Tyndale RF
Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
[TBL] [Abstract][Full Text] [Related]
5. A review of smoking behavior and smokers evidence (chemical modification, inducing nicotine metabolism, and individual variations by genotype: dopaminergic function and personality traits).
Iwahashi K; Aoki J
Drug Chem Toxicol; 2009; 32(4):301-6. PubMed ID: 19793020
[TBL] [Abstract][Full Text] [Related]
6. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
[TBL] [Abstract][Full Text] [Related]
7. Smoking cessation program and CYP2A6 polymorphism.
Ozaki S; Oyama T; Isse T; Kagawa N; Uramoto H; Sugio K; Yasumoto K; Kono K; Kawamoto T
Front Biosci; 2006 Sep; 11():2590-7. PubMed ID: 16720336
[TBL] [Abstract][Full Text] [Related]
8. The role of CYP2A6 in the emergence of nicotine dependence in adolescents.
Audrain-McGovern J; Al Koudsi N; Rodriguez D; Wileyto EP; Shields PG; Tyndale RF
Pediatrics; 2007 Jan; 119(1):e264-74. PubMed ID: 17130279
[TBL] [Abstract][Full Text] [Related]
9. Whole deletion of CYP2A6 gene (CYP2A6AST;4C) and smoking behavior.
Iwahashi K; Waga C; Takimoto T
Neuropsychobiology; 2004; 49(2):101-4. PubMed ID: 14981342
[TBL] [Abstract][Full Text] [Related]
10. A meta-analytic review of the CYP2A6 genotype and smoking behavior.
Carter B; Long T; Cinciripini P
Nicotine Tob Res; 2004 Apr; 6(2):221-7. PubMed ID: 15203795
[TBL] [Abstract][Full Text] [Related]
11. An association of CYP2A6 genotype and smoking topography.
Strasser AA; Malaiyandi V; Hoffmann E; Tyndale RF; Lerman C
Nicotine Tob Res; 2007 Apr; 9(4):511-8. PubMed ID: 17454707
[TBL] [Abstract][Full Text] [Related]
12. A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumption.
Tyndale RF; Pianezza ML; Sellers EM
Nicotine Tob Res; 1999; 1 Suppl 2():S63-7; discussion S69-70. PubMed ID: 11768189
[TBL] [Abstract][Full Text] [Related]
13. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
Schoedel KA; Hoffmann EB; Rao Y; Sellers EM; Tyndale RF
Pharmacogenetics; 2004 Sep; 14(9):615-26. PubMed ID: 15475735
[TBL] [Abstract][Full Text] [Related]
14. Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.
Nakajima M; Kuroiwa Y; Yokoi T
Drug Metab Rev; 2002 Nov; 34(4):865-77. PubMed ID: 12487152
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.
Ariyoshi N; Miyamoto M; Umetsu Y; Kunitoh H; Dosaka-Akita H; Sawamura Y; Yokota J; Nemoto N; Sato K; Kamataki T
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):890-4. PubMed ID: 12223434
[TBL] [Abstract][Full Text] [Related]
16. Nicotine metabolism defect reduces smoking.
Pianezza ML; Sellers EM; Tyndale RF
Nature; 1998 Jun; 393(6687):750. PubMed ID: 9655391
[No Abstract] [Full Text] [Related]
17. Decreasing smoking behaviour and risk through CYP2A6 inhibition.
Sellers EM; Tyndale RF; Fernandes LC
Drug Discov Today; 2003 Jun; 8(11):487-93. PubMed ID: 12818518
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between smoking and CYP2A6 gene polymorphisms in A Japanese population.
Zhang X; Amemo K; Ameno S; Iwahashi K; Kinoshita H; Kubota T; Mostofa J; Ijiri I
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2001 Oct; 36(5):486-90. PubMed ID: 11725533
[TBL] [Abstract][Full Text] [Related]
19. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.
O'Loughlin J; Paradis G; Kim W; DiFranza J; Meshefedjian G; McMillan-Davey E; Wong S; Hanley J; Tyndale RF
Tob Control; 2004 Dec; 13(4):422-8. PubMed ID: 15564629
[TBL] [Abstract][Full Text] [Related]
20. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
